AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $4.15M invested in Akari Therapeutics in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$297K
2
+$63.5K
3
+$37.3K
4
TSS
Two Sigma Securities
New York
+$22K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$18K

Top Sellers

1
-$53K
2
-$36K
3
-$6K
4
UBS Group
UBS Group
Switzerland
-$4K
5
Morgan Stanley
Morgan Stanley
New York
-$760
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.63M
2
$791K
3
$301K
4
$297K
5
$64K
6
$22K
7
$18K
8
$18K
9
$5K
10
$2K
11
$2K
12
$2K
13
$1K
14
–
15
–
16
–
17
–